Standard Biotools (LAB) Gross Margin (2010 - 2026)

Standard Biotools (LAB) has 17 years of Gross Margin data on file, last reported at 53.48% in Q1 2026.

• On a quarterly basis, Gross Margin fell 116.0% year-over-year to 53.48% in Q1 2026; TTM through Mar 2026 was 49.62%, a 51.0% decrease from a year earlier, with the FY2025 full-year figure at 49.86%, up 54.0% from the prior year.
• Gross Margin for Q1 2026 stood at 53.48%, up from 47.83% in the prior quarter.
• Over the last five years, Gross Margin for LAB reached as high as 92.73% in Q1 2022 and fell as low as 23.58% in Q2 2022.
• Historically, Gross Margin has averaged 49.19% across 5 years, with a median of 48.51% in 2025.
• On a YoY basis, Gross Margin climbed as much as 2829 bps in 2022 and fell as far as 7022 bps in 2022.
• Year by year, Gross Margin stood at 41.33% in 2022, then rose by 15 bps to 47.39% in 2023, then declined by 3 bps to 45.84% in 2024, then grew by 4 bps to 47.83% in 2025, then rose by 12 bps to 53.48% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 53.48% in Q1 2026, 47.83% in Q4 2025, and 48.51% in Q3 2025.